Elevance Health
1,525 hedge funds and large institutions have $90.8B invested in Elevance Health in 2023 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 576 increasing their positions, 571 reducing their positions, and 97 closing their positions.
22% more funds holding in top 10
Funds holding in top 10: 45 → 55 (+10)
21% more first-time investments, than exits
New positions opened: 117 | Existing positions closed: 97
13% more call options, than puts
Call options by funds: $619M | Put options by funds: $548M
1% more repeat investments, than reductions
Existing positions increased: 576 | Existing positions reduced: 571
0% more funds holding
Funds holding: 1,522 → 1,525 (+3)
0.32% less ownership
Funds ownership: 88.47% → 88.15% (-0.32%)
2% less capital invested
Capital invested by funds: $93B → $90.8B (-$2.19B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$347M |
| 2 |
Eagle Capital Management (New York)
New York
|
+$287M |
| 3 |
BWA
Brave Warrior Advisors
New York
|
+$139M |
| 4 |
Two Sigma Advisers
New York
|
+$127M |
| 5 |
DCP
D1 Capital Partners
New York
|
+$122M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$710M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$628M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$333M |
| 4 |
State Street
Boston,
Massachusetts
|
-$242M |
| 5 |
Man Group
London,
United Kingdom
|
-$233M |
ELV Hedge Fund Activity: Q3 2023 in Review
1,525 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q3 2023, worth a combined $90.8B — down 2.3% from $93B a quarter earlier.
Buyers outnumbered sellers: 117 funds opened new ELV positions and 97 closed out — a net gain of 20 holders — while 576 added to existing stakes and 571 trimmed.
The largest buyer was Millennium Management, adding an estimated $347M. The largest seller was Capital International Investors, cutting an estimated $710M.
- 1,525 institutional investors held Elevance Health (ELV) as of Q3 2023, up from 1,522 in Q2 2023.
- Funds reported $90.8B of Elevance Health stock for Q3 2023, down 2.3% quarter-over-quarter.
- 117 funds opened new Elevance Health positions in Q3 2023 and 97 closed out, a net change of +20 holders.
- The largest Elevance Health buyer in Q3 2023 was Millennium Management, an estimated $347M added.
- The largest Elevance Health seller in Q3 2023 was Capital International Investors, an estimated $710M sold.
Based on aggregated 13F filings for Q3 2023.